Displaying drugs 2401 - 2425 of 2808 in total
Arsthinol
Arsthinol (INN) is an antiprotozoal agent that was first synthesized by Ernst A.H. Friedheim in 1949 via the complexing of acetarsol with 2,3-dimercaptopropanol. It has since been demonstrated that the agent possesses activity against amoebas and yaws. Considered well tolerated when compared to other related trivalent organoarsenicals, arsthinol has even...
Experimental
PF-03715455
PF-03715455 has been used in trials studying the treatment of Asthma, Pulmonary Disease, Chronic Obstructive, and Chronic Obstructive Pulmonary Disease (COPD).
Investigational
Alvespimycin
Alvespimycin is a derivative of geldanamycin and heat shock protein (HSP) 90 inhibitor. It has been used in trials studying the treatment of solid tumor in various cancer as an antitumor agent. In comparison to the first HSP90 inhibitor tanespimycin, it exhibits some pharmacologically desirable properties such as reduced metabolic...
Investigational
AZD-9056
AZD9056 has been used in trials studying the basic science and treatment of Rheumatoid Arthritis.
Investigational
Rokitamycin
Experimental
(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate
Experimental
Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid
A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [PubChem]
Experimental
GE-2270A
Experimental
Aclarubicin
Investigational
5'-O-(N-Ethyl-Sulfamoyl)Adenosine
Experimental
Alpha-Ribazole-5'-Phosphate Derivative
Experimental
Uridine-5'-Diphosphate
A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem]
Experimental
2'-Deoxyguanosine-5'-Diphosphate
Experimental
Beta-Hydroxyaspartic Acid
Experimental
Uridine monophosphate
5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.
Experimental
TMP
Experimental
Inhibitor BEA409
Experimental
2'-O-butyl-5-methyluridine
Experimental
AZD-8330
AZD-8330 is a potent, selective, orally active MEK inhibitor that blocks signal transduction pathways implicated in cancer cell proliferation and survival. AZD-8330 has shown tumor suppressive activity in multiple preclinical models of human cancer including melanoma, pancreatic, colon, lung, and breast cancers.
Investigational
Displaying drugs 2401 - 2425 of 2808 in total